Advancements in tadalafil formulation and transdermal delivery: a comprehensive review
Abstract
Consequently, the developments in transdermal delivery systems for Tadalafil are a shift in the management of erectile dysfunction and benign prostatic hyperplasia.The main disadvantages of conventional oral formulations are poor absorption, first-pass metabolism, and a number of side effects that may compromise patient compliance.Nonetheless, there are drawbacks associated with these formulation types, which have been overcome to a large extent by transdermal formulations such as patches and formulations at the nano scale.It has also reduced the bioavailability and steady state drug concentrations than that of transdermal Tadalafil, which increases the therapeutic efficacy.Further, the slow and sustained release typical of transdermal delivery has been linked to lessened system toxicities, thus improving patient compliance.Research work has also started to support these innovations and the potential of the transdermal Tadalafil in offering better results than the oral Tadalafil has been proved.Further studies are being conducted on the ways to improve the efficiency of Tadalafil administration, and all of them show a positive trend in this regard.As the methods of transdermal drug delivery develop all over the world, the possibility to enhance the usage of Tadalafil for patients can be seen.This shift is not only expected to increase the effectiveness of therapy but also to increase the general quality of life of patients.Subsequent studies will also be required to…
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.